Prosecution Insights
Last updated: May 29, 2026

Inbiose N V

9 pending office actions • 4 art units • 7 examiners • 0 of 9 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
3
Non-Final OAs
6
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
1
Due this week
5
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 7 days (1)Due ≤ 30 days (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (44%)
3
Easy (33%)
2
Unknown (22%)

Rejection Statute Mix

BucketCases
§103 only3 (33%)
§102 only1 (11%)
§112 only3 (33%)
No statute on record2 (22%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

9
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
EIX, EMILY FAY 3 52.2% +64.7%
ROBINSON, HOPE A 1 67.9% +43.2%
RAMIREZ, DELIA M 1 65.0% +56.5%
PAK, YONG D 1 74.4% +13.7%
SPANGLER, JOSEPH RANKIN 1 38.5% +63.3%
MOEHLMAN, ANDREW TERRY 1 67.4% +62.4%
HOLLAND, PAUL J 1 57.5% +64.7%

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18720533 PRODUCTION OF ALPHA-1,4-FUCOSYLATED COMPOUNDS ROBINSON, HOPE A 52d overdue
18718677 PRODUCTION OF ALPHA-1,3-FUCOSYLATED COMPOUNDS RAMIREZ, DELIA M 30d overdue
18041022 PRODUCTION OF FUCOSYLATED LACTOSE STRUCTURES BY A CELL EIX, EMILY FAY 8d overdue
17904189 PRODUCTION OF GLYCOSYLATED PRODUCT IN HOST CELLS SPANGLER, JOSEPH RANKIN 6d
18041137 CELLULAR PRODUCTION OF SIALYLATED DI AND/OR OLIGOSACCHARIDES EIX, EMILY FAY 20d
17787115 Production of Sialylated Oligosaccharide in Host Cells MOEHLMAN, ANDREW TERRY 22d
18041167 PRODUCTION OF GLCNAC CONTAINING BIOPRODUCTS IN A CELL PAK, YONG D 23d
17627088 PRODUCTION OF FUCOSYLLACTOSE IN HOST CELLS HOLLAND, PAUL J 26d

Top Art Units

Art UnitApps
1652 3
1653 3
1656 2
1655 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18720533 PRODUCTION OF ALPHA-1,4-FUCOSYLATED COMPOUNDS ROBINSON, HOPE A 1652 §112 Final Rejection 52d overdue Pending Jun 14, 2024
18718677 PRODUCTION OF ALPHA-1,3-FUCOSYLATED COMPOUNDS RAMIREZ, DELIA M 1652 §112 Non-Final OA 30d overdue Pending Jun 11, 2024
18261806 PRODUCTION OF OLIGOSACCHARIDES COMPRISING LN3 AS CORE STRUCTURE IN HOST CELLS EIX, EMILY FAY 1653 Other Non-Final OA 27d Pending Jul 17, 2023
18041167 PRODUCTION OF GLCNAC CONTAINING BIOPRODUCTS IN A CELL PAK, YONG D 1652 §103 Final Rejection 23d Pending Feb 09, 2023
18041137 CELLULAR PRODUCTION OF SIALYLATED DI AND/OR OLIGOSACCHARIDES EIX, EMILY FAY 1653 §112 Final Rejection 20d Pending Feb 09, 2023
18041022 PRODUCTION OF FUCOSYLATED LACTOSE STRUCTURES BY A CELL EIX, EMILY FAY 1653 Other Final Rejection 8d overdue Pending Feb 08, 2023
17904189 PRODUCTION OF GLYCOSYLATED PRODUCT IN HOST CELLS SPANGLER, JOSEPH RANKIN 1656 §102 Final Rejection 6d Pending Aug 12, 2022
17787115 Production of Sialylated Oligosaccharide in Host Cells MOEHLMAN, ANDREW TERRY 1655 §103 Final Rejection 22d Pending Jun 17, 2022
17627088 PRODUCTION OF FUCOSYLLACTOSE IN HOST CELLS HOLLAND, PAUL J 1656 §103 Non-Final OA 26d Pending Jan 13, 2022

Managing Inbiose N V's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month